FDA approves mHealth headband as drug-free migraine remedy

By Admin
Written by Alyssa Clark Recently, the Food and Drug Administration recommended and approved a newly developed technology that can set all migraine-suf...

Written by Alyssa Clark

 

Recently, the Food and Drug Administration recommended and approved a newly developed technology that can set all migraine-suffers at ease, because there proves to be hope after all. With 12 percent of the U.S.’s population suffering from migraines, this problem has been a long-time coming in terms of finding a solution. Finally, this plastic headband-like medical device named Cefaly works to not only treat ongoing migraines, but works to prevent migraines from ever occurring in the first place.  What’s the best thing about this new device? This remedy remains entirely drug free and places the relief of pain onto this new device, rather than onto a pill bottle as we have seen in many years previously. The wave of moving away from traditional prescriptions and heavily-medicated ailments is something we can all be excited about— especially when drug-free remedies such as this become available to the public.

"Cefaly provides an alternative to medication for migraine prevention," said Christy Foreman, director of the Office of Device Evaluation at the FDA's Center for Devices and Radiological Health, according to a news release. "This may help patients who cannot tolerate current migraine medications for preventing migraines or treating attacks."

The headband is built on TENS stimulation, which is described as Transcutaneous electrical nerve stimulation, and works by delivering a small electric current through an electrode on the forehead. The electricity that is pumped to the head stimulates the trigeminal nerve, which has been long tied to being the cause of migraines.

The study found that, “Safety and efficacy for the device was evaluated via a study conducted on 67 people living in Belgium. The participants had two migraine attacks a month and weren't on any medications to prevent headaches. Researchers also looked at data from 2,313 Cefaly users in France and Belgium to assess patient satisfaction.”

Belgium’s STX-Med is the company behind this one-of-a-kind technology, making the headband battery-operated. Cefaly has not only proved to be an example of moving away from the prescription-heavy past, but can now be attained in the U.S. with a prescription from a medical professional.

“Data from the patient satisfaction study showed that over half (53 percent) of the participants were satisfied with the treatment and were willing to buy the device. Common problems of using the device were sleepiness during treatment and headache after treatment session.”

 

Share
Share

Featured Articles

Healthcare staff shortage creates cyber security risk

The healthcare industry is chronically understaffed which is exacerbating cyber security risk, says SailPoint’s Steve Bradford, in new research report

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Medical Devices & Pharma

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19